TKL Research

QuintilesIMS to acquire TKL Research’s Clinical Trials Division

Monday, November 21, 2016

TKL Research, a dermatology specialty CRO, has signed an agreement to sell its Clinical Trials Division (CTD) to QuintilesIMS. Upon closing, TKL’s CTD will become part of Novella Clinical, a Quintiles company. Moving forward, TKL Research will retain its Research Clinics Division (RCD) as TKL Research, which operates full-service inpatient and outpatient phase I facilities in northern New Jersey.

[Read More]

TKL Research opens new primary research clinic

Monday, March 24, 2014

TKL Research, a full-service CRO, has officially opened its new primary research clinic in Fair Lawn, N.J. This 25,000-square-foot facility offers a 70% increase in space over TKL’s former clinic, making it possible to create a sophisticated 30-bed phase I pharmacology unit and multiple examination rooms for outpatient studies.

[Read More]

TKL Research names VP of operational excellence

Monday, August 1, 2011

TKL Research has named Kevin Vernarec, vice president of operational excellence. In this new role, Vernarec will carry the responsibility for ensuring that all clinical research organization (CRO) systems and processes are performed with optimum quality and are executed utilizing appropriately allocated resources.

[Read More]